Journey Colab

📍 San Francisco, United States🗓 Founded 2020👥 12 employees💰 Last funded Jul 2021
Pharmaceutical Manufacturing🌐 journeycolab.com
Website LinkedIn
Journey Colab is unlocking the science of psychedelics to build a new model of addiction care combining the potential of neuroplasticity-promoting therapeutics with psychotherapy and community support. Our lead compound is synthetic Mescaline HCl for patients with alcohol use disorder (AUD), who are in desperate need of durable remission from this chronic, relapsing condition. Through our unique stakeholder structure, we have built an experienced team dedicated to our mission of creating scientifically rigorous and clinically validated treatments and improving equitable access to care.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Journey Colab?
Journey Colab has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Journey Colab last raise funding?
The most recent investment in Journey Colab recorded on gritt.io was in July 2021.
When was Journey Colab founded?
Journey Colab was founded in 2020.
What industry is Journey Colab in?
Journey Colab operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Journey Colab based?
Journey Colab is headquartered in San Francisco, United States.